• Corpus ID: 11339170

Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.

@article{Bhat2001ResveratrolEC,
  title={Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.},
  author={Krishna P Bhat and John M. Pezzuto},
  journal={Cancer research},
  year={2001},
  volume={61 16},
  pages={
          6137-44
        }
}
Trans-3,4',5-trihydroxystilbene (resveratrol), a polyphenolic compound found in the human diet, was reported recently to serve as an estrogen agonist with cultured MCF-7 cells transfected with estrogen response element-luciferase reporter plasmids. As currently shown, treatment of cultured human endometrial adenocarcinoma (Ishikawa) cells with resveratrol (concentrations as high as 10 microM) did not significantly increase the levels of an estrogen-inducible marker enzyme, alkaline phosphatase… 

Figures and Tables from this paper

Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
TLDR
The data suggest that resveratrol may have beneficial effects if used as a chemopreventive agent for breast cancer, and exerts mixed estrogen agonist/antagonist activities in some mammary cancer cell lines, but in the presence of E2, resver atrol functions as an antiestrogen.
Resveratrol and Endometrium
TLDR
It is suggested that resveratrol, at high doses, has the potential benefit to reduce proliferation of human endometrium through ESR1.
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells
TLDR
High-dose of resveratrol exerts tumoricidal activity over uterine cancer cells and regulates COX expression in these cells, but possibly other enzymes involved in prostaglandin synthesis that act downstream of the COXs.
Acetaminophen exhibits weak antiestrogenic activity in human endometrial adenocarcinoma (Ishikawa) cells.
TLDR
These studies indicate acetaminophen exerts weak antiestrogenic activity in Ishikawa cells without directly binding ERalpha or ERbeta, and augmented 4-hydroxy-tamoxifen reduction of alkaline phosphatase activity.
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
TLDR
In vivo, resveratrol blocks the multistep process of carcinogenesis at various stages: it blocks carcinogen activation by inhibiting aryl hydrocarbon-induced CYP1A1 expression and activity, and suppresses tumor initiation, promotion and progression.
Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER α
TLDR
It is found that Res belongs to the type I estrogens, and both Res and E2 had concentration‐dependent growth inhibitory effects in cells expressing wtER and D351Y ER.
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2
Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
...
...

References

SHOWING 1-10 OF 55 REFERENCES
Antiproliferative effect of synthetic resveratrol on human breast epithelial cells.
TLDR
Results indicate that resveratrol has a direct antiproliferative effect on human breast epithelial cells that is independent of the estrogen receptor status of the cells, and is a potential chemopreventive agent for both hormone responsive and non-responsive breast cancers.
Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
TLDR
The results reveal that genistein is unique among the flavonoids tested, in that it has potent estrogen agonist and cell growth-inhibitory actions over a physiologically relevant concentration range.
Differential response of immature rat uterine tissue to ethinylestradiol and the red wine constituent resveratrol
TLDR
An estrogenic potential of RES could not be substantiated in this in vivo study, although the most effective route of administration and extremely high doses were used and plasma levels were in the range reported to be effective in vitro.
Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
TLDR
The results show that resveratrol, a partial ER agonist itself, acts as an ER antagonist in the presence of estrogen leading to inhibition of human breast cancer cells.
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
TLDR
It is concluded that resveratrol is a phytoestrogen and that it exhibits variable degrees of estrogen receptor agonism in different test systems, which broaden the spectrum of its biological actions and may be relevant to the reported cardiovascular benefits of drinking wine.
Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.
TLDR
The results suggest that the intrinsic metastatic potential of cancer cells may affect their responses to chemopreventive agents such as resveratrol.
Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
TLDR
It is demonstrated that PE are active in lactotroph cells of the pituitary, and the estrogenic effects of PE in PR1 cells were ER dependent, in that addition of the antiestrogen ICI-182,780 inhibited prolactin response.
...
...